A financial toxicity tumor board has effectively reduced financial toxicity for cancer patients, researchers say.

Researchers sought to determine whether combination therapy with zanubrutinib, obinutuzumab, and venetoclax would be effective for TP53-mutant MCL.

An analysis of 10 cancer treatment sites revealed that many pediatric patients do not receive care pathway-consistent and CPG-consistent care.

This move is the latest in a series of attempts by the Trump administration to eliminate DEI/DEIA programs and reduce NIH funding.

HealthDay News — Annual whole-body, low-dose computed tomography (WBLDCT) can improve the management of smoldering multiple myeloma (SMM), according to a study published online March 25 in the Journal ...

Consensus statements on managing childhood dystonia were recently released by a panel of experts in pediatric palliative care.

The Fatigue Scale provides a reliable measure of fatigue in most populations of pediatric patients with cancer.